Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Delivery systems for gene-based vaccines.

T W Dubensky1, M A Liu, J B Ulmer

  • 1Vaccines Research and Gene Therapy, Chiron Corporation, Emeryville, California 94608, USA.

Molecular Medicine (Cambridge, Mass.)
|November 9, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DNA vaccines.

Methods in molecular medicine·2011
Same author

The second Geneva Consensus: Recommendations for novel live TB vaccines.

Vaccine·2010
Same author

Public health. The cholera crisis in Africa.

Science (New York, N.Y.)·2009
Same author

Topic in Review: Vaccines in the 21st century.

The Western journal of medicine·2008
Same author

Plasmid DNA-based alphavirus expression vectors for nucleic acid immunization.

IDrugs : the investigational drugs journal·2008
Same author

Pre-clinical evaluation of a CEA DNA prime/protein boost vaccination strategy against colorectal cancer.

Scandinavian journal of immunology·2007
Same journal

METTL3/YTHDC1 axis-mediated m<sup>6</sup>A modification of Foxo1 mRNA promote endothelial autophagic apoptosis in diabetic atherosclerosis.

Molecular medicine (Cambridge, Mass.)·2026
Same journal

Low-PSMA hormone-sensitive prostate cancer: a distinct clinical and molecular state.

Molecular medicine (Cambridge, Mass.)·2026
Same journal

Cardiac extracellular vesicle proteomics identifies mitochondrial and contractile dysfunction in carbon monoxide poisoning and their reversal by hyperbaric oxygen therapy.

Molecular medicine (Cambridge, Mass.)·2026
Same journal

Acute anti-obesity treatment with celastrol reduces body weight, cerebral inflammation and metabolic imbalances in mice.

Molecular medicine (Cambridge, Mass.)·2026
Same journal

Integrative machine learning and CRISPR/Cas9 analysis reveals the role of APOE in lipid metabolism-associated kidney fibrosis.

Molecular medicine (Cambridge, Mass.)·2026
Same journal

Immunogenic implications of translational readthrough modulate the association of F8 nonsense mutations with inhibitors in Hemophilia A.

Molecular medicine (Cambridge, Mass.)·2026
See all related articles

New gene-based vaccine strategies enhance cellular immunity. Recent advancements in plasmid DNA and alphaviral replicon vector delivery systems show increased potency for vaccines generating cellular immunity alongside antibodies.

Area of Science:

  • Immunology
  • Vaccinology
  • Molecular Biology

Background:

  • Cytotoxic T lymphocytes (CTLs) are crucial for pathogen and cancer immunity.
  • Understanding antigen processing has increased focus on vaccines inducing cellular immunity.
  • Gene-based vaccines (DNA plasmids, viral vectors) are promising but require enhanced potency.

Purpose of the Study:

  • To review recent developments in gene-based vaccine technologies.
  • To highlight new formulation and delivery approaches for plasmid DNA and alphaviral replicon vectors.
  • To discuss strategies for increasing the potency of gene-based vaccines.

Main Methods:

  • Review of pre-clinical and clinical trial data on gene-based vaccines.
  • Analysis of novel formulation techniques for DNA and viral vector vaccines.

Related Experiment Videos

  • Evaluation of delivery systems enhancing gene expression and immune response.

    • Main Results:

    • First-generation DNA plasmid vaccines showed broad efficacy in animal models.
    • Early clinical trials indicated a need for improved immunogenicity and potency.
    • New formulation and delivery methods have successfully increased the potency of gene-based vaccines.

    Conclusions:

    • Advancements in gene-based vaccine technology are crucial for effective cellular immunity.
    • Optimized formulation and delivery of plasmid DNA and alphaviral vectors enhance vaccine potency.
    • Future vaccine development should focus on these improved gene-based strategies for robust immune responses.